Autonomix Medical, Inc.
AMIX
NASDAQ·Healthcare·Medical - Devices·Mkt cap $2.5M
$4.59
▼ -1.92%
P/E
—
Mkt Cap
$2.5M
52-Wk Range
$2.44–$32.55
52-Week Range
$2.44 - $32.55
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 81.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary catheter-based microchip-enabled sensing array technology
- Novel approach to peripheral neural signal detection and differentiation
- Early-stage development position in underserved neuromodulation market
- Intellectual property portfolio focused on peripheral nervous system applications
Bear Case
1 risk
- Low volatility (beta -1.3).
Growth
Stable outlook
Advancement through clinical development and regulatory approvals
Value
Valuation data unavailable
Momentum
Falling
-45.7% over 3m
Quality
Loss-making
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying AMIX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 11, 2026
AUG 12, 2026
Reported EPS of -$5.02 vs -$6.40 consensus (+21.6% surprise).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+21.6%
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q1 24
Q2 24
Q3 24
Q4 25
Q1 25
Q2 25
Q3 25
Q1 27
$0
$0
$0
$0
$0
$0
$0
$0
Margins · last 8Q
No margin history available.
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How AMIX stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related